Cargando…

Clinical utility of circulating tumor-associated cells to predict and monitor chemo-response in solid tumors

PURPOSE: Selection of cytotoxic chemotherapy agents (CCA) based on pre-treatment evaluation of drug sensitivities is a desirable but unmet goal for personalized anticancer treatment strategies. Prior attempts to correlate in vitro Chemo-Response Profiles (CRP) of tumor explants or Circulating Tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crook, Timothy, Gaya, Andrew, Page, Raymond, Limaye, Sewanti, Ranade, Anantbhushan, Bhatt, Amit, Patil, Sanket, Kumar, Prashant, Patil, Darshana, Akolkar, Dadasaheb
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870597/ https://www.ncbi.nlm.nih.gov/pubmed/33170321 http://dx.doi.org/10.1007/s00280-020-04189-8

Ejemplares similares

Evaluation of circulating tumor cell clusters for pan‐cancer noninvasive diagnostic triaging
por: Gaya, Andrew, et al.
Publicado: (2020)

Improved Treatment Outcomes by Using Patient Specific Drug Combinations in Mammalian Target of Rapamycin Activated Advanced Metastatic Cancers
por: Crook, Timothy, et al.
Publicado: (2021)

Accurate Screening for Early-Stage Breast Cancer by Detection and Profiling of Circulating Tumor Cells
por: Crook, Timothy, et al.
Publicado: (2022)

Circulating ensembles of tumor‐associated cells: A redoubtable new systemic hallmark of cancer
por: Akolkar, Dadasaheb, et al.
Publicado: (2019)

Adaptive, Iterative, Long-Term Personalized Therapy Management in a Case of Stage IV Refractory NSCLC
por: Ranade, Anantbhushan, et al.
Publicado: (2019)

Accurate prostate cancer detection based on enrichment and characterization of prostate cancer specific circulating tumor cells
por: Limaye, Sewanti, et al.
Publicado: (2023)

A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
por: Limaye, Sewanti, et al.
Publicado: (2020)

Addendum: A case report of androgen receptor inhibitor therapy in recurrent high-grade serous ovarian cancer
por: Limaye, Sewanti, et al.
Publicado: (2022)

Response to pazopanib‐based combination regimen in a case of FGFR3 amplified gastric adenocarcinoma
por: Limaye, Sewanti, et al.
Publicado: (2021)

Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
por: Nagarkar, Rajnish, et al.
Publicado: (2020)

Addendum: Liquid biopsy and multi-analyte testing guided treatment of HER2 positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy
por: Nagarkar, Rajnish, et al.
Publicado: (2022)

Multi-analyte liquid biopsies for molecular pathway guided personalized treatment selection in advanced refractory cancers: A clinical utility pilot study
por: Patil, Darshana, et al.
Publicado: (2022)

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers: results from the RESILIENT trial
por: Nagarkar, Rajnish, et al.
Publicado: (2019)

Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers
por: Page, Raymond, et al.
Publicado: (2022)

Development and validation of a multigene variant profiling assay to guide targeted and immuno therapy selection in solid tumors
por: Akolkar, Dadasaheb, et al.
Publicado: (2021)

Chemo-immunoablation of solid tumors: A new concept in tumor ablation
por: Meng, Liangliang, et al.
Publicado: (2023)

Utilization of Circulating Tumor Cells in the Management of Solid Tumors
por: Kurniali, Peter C., et al.
Publicado: (2023)

Circulating Tumor Cells in Oral Cancer
por: Augustine, Dominic, et al.
Publicado: (2015)

Genetic variability in minor capsid protein (L2 gene) of human papillomavirus type 16 among Indian women
por: Mane, Arati, et al.
Publicado: (2022)

Integrated proteomics and phosphoproteomics revealed druggable kinases in neoadjuvant chemotherapy resistant tongue cancer
por: George, Irene A., et al.
Publicado: (2022)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
por: Capuozzo, Maurizio, et al.
Publicado: (2023)

Expression of chemokine receptors on circulating tumor cells in patients with solid tumors
por: Fusi, Alberto, et al.
Publicado: (2012)

Association of Immune-Related Adverse Effects and Survival in Solid Tumor Patients Treated with PD1 Inhibitors
por: Kapoor, Akhil, et al.
Publicado: (2022)

Giant Cell Tumor in the Distal End of the Ulna Managed by Darrach's Procedure: A Case Report
por: Kandarkar, Madhavi M, et al.
Publicado: (2023)

Circulating tumor cells: A promising marker of predicting tumor response in rectal cancer patients receiving neoadjuvant chemo-radiation therapy
por: Sun, Wenjie, et al.
Publicado: (2016)

Utilizing Plasma Circulating Tumor DNA Sequencing for Precision Medicine in the Management of Solid Cancers
por: Cha, Yongjun, et al.
Publicado: (2023)

Tumor Exosome Mimicking Nanoparticles for Tumor Combinatorial Chemo-Photothermal Therapy
por: Tian, Ran, et al.
Publicado: (2020)

Remodeling of tumor microenvironment for enhanced tumor chemodynamic/photothermal/chemo-therapy
por: Zhang, Ying, et al.
Publicado: (2022)

Tranilast-induced stress alleviation in solid tumors improves the efficacy of chemo- and nanotherapeutics in a size-independent manner
por: Papageorgis, Panagiotis, et al.
Publicado: (2017)

Juvenile idiopathic arthritis
por: Bhatt, Krupa H, et al.
Publicado: (2014)

Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non–Small Cell Lung Cancer
por: Pellini, Bruna, et al.
Publicado: (2023)

Using single-cell sequencing technology to detect circulating tumor cells in solid tumors
por: Xu, Jiasheng, et al.
Publicado: (2021)

Immune checkpoint inhibitors in patients with solid tumors and poor performance status: A prospective data from the real-world settings
por: Kapoor, Akhil, et al.
Publicado: (2021)

Type XX Collagen Is Elevated in Circulation of Patients with Solid Tumors
por: Thorlacius-Ussing, Jeppe, et al.
Publicado: (2022)

A real‐world data of Immune checkpoint inhibitors in solid tumors from India
por: Noronha, Vanita, et al.
Publicado: (2021)

The role of HIF-1α in chemo-/radioresistant tumors
por: Xia, Yu, et al.
Publicado: (2018)

Correction to: Using single-cell sequencing technology to detect circulating tumor cells in solid tumors
por: Xu, Jiasheng, et al.
Publicado: (2022)

Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype
por: Swayden, Mirna, et al.
Publicado: (2018)

Tumor Targeting Chemo- and Photodynamic Therapy Packaged in Albumin for Enhanced Anti-Tumor Efficacy
por: Zheng, Ke, et al.
Publicado: (2020)

Chemo-/immuno-/radiotherapy combination in treatment of solid cancer
por: Käsmann, Lukas, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2pksf0vkoktgpl1hfm0ui2fk94